INMD
InMode Ltd.
$14.14
+0.50% 2026-10-20
Healthcare
INMDSPY
1W
-1.2%
1M
-1.5%
3M
-7.9%
6M
-2.5%
YTD
-3.7%
1Y
-11.7%
Live chart
Loading live chart…
Grades vs sector
MomentumNot enough data yet–
Momentum
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
GrowthNot enough data yet–
Growth
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
ValueNot enough data yet–
Value
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
ProfitabilityNot enough data yet–
Profitability
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
Revisions
Not enough data yet
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 5 live models right now.
Quality Growth
not ranked (outside this model's universe or screens)
Momentum Top 15not ranked (outside this model's universe or screens)
Momentum Blendnot in the current book
New Highs Growthnot ranked (outside this model's universe or screens)
Conviction 20not in the current book
News
More newsSteel Partners Holdings L.P. Issues Open Letter to All InMode Stakeholders and Sets October 30, 2026 Expiration for Its $16.75 Per Share All-Cash Offer
Business Wire · Oct 19
InMode Sees Up to $92 Million in Q3 Revenue; Shares Up Pre-Bell
MT Newswires · Oct 13
InMode to Report Third Quarter 2026 Financial Results on November 11, 2026, Expects Third Quarter Revenue of $91.8 Million to $92.0 Million, Reiterates FY 2026 Revenue Guidance Between $365M-$375M
PR Newswire · Oct 13
InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool
PR Newswire · Sep 09
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
CNW Group · Sep 01
Key stats
Market cap$813.7M
P/E (trailing)11.7
P/E (forward)10.3
52-week range12.72 – 16.67
Revenue growth (YoY, latest qtr)-0.0%
Dividend yield0.00%
Analyst consensusHold (3)
Mean price target$16.17 (+14%)
Valuation and fundamentals
Valuation & fundamentals
No US-GAAP 10-K/10-Q financials in SEC data (foreign filers report on Form 20-F, often under IFRS).
Earnings
Next report: 2026-11-11 · before open · EPS est 0.32
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-08-05 | 0.33 | 0.35 | +5.4% |
| 2026-05-06 | 0.30 | 0.25 | -16.1% |
| 2026-02-10 | 0.42 | 0.46 | +10.4% |
| 2025-11-05 | 0.35 | 0.38 | +7.0% |
| 2025-07-30 | 0.41 | 0.47 | +14.5% |
| 2025-04-28 | 0.35 | 0.31 | -12.2% |
| 2025-02-04 | 0.50 | 0.42 | -16.3% |
| 2024-10-30 | 0.61 | 0.70 | +13.9% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $95.6M | -0.0% |
| 2026-03-31 | $82.0M | – |
| 2025-12-31 | $103.9M | – |
| 2025-09-30 | $93.2M | – |
| 2025-06-30 | $95.6M | – |
Analyst actions
Barclays
PT $19
2026-05-07 · main
Overweight → OverweightPT $19
Baird
PT $14
2026-05-07 · main
Neutral → NeutralPT $14
Canaccord Genuity
PT $15
2025-12-17 · main
Hold → HoldPT $15
UBS
PT $16
2025-11-06 · main
Neutral → NeutralPT $16
Canaccord Genuity
PT $16
2025-10-10 · main
Hold → HoldPT $16
Needham
2025-10-10 · reit
Hold → HoldInsider trades
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
Stats refreshed 2026-10-20 18:14:11 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteau
Coteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.